Promising Response with PI3K Inhibitor for a Patient with Heavily Pretreated PIK3CA Mutation Head-and-Neck Cancer

Promising Response with PI3K Inhibitor for a Patient with Heavily Pretreated PIK3CA Mutation Head-and-Neck Cancer

The treatment options for patients with head-and-neck squamous cell carcinoma (HNSCC) are limited when the disease progresses after taking platinum, a PD-1 inhibitor, and cetuximab. To develop new agents for managing such pretreated malignancies, therapies targeting carcinogenic pathways could be po...

Full description

Saved in:
Bibliographic Details
Main Authors: Ming-Jing Lee, Hsiang-Fong Kao
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-04-01
Series:Journal of Cancer Research and Practice
Subjects:
alpelisib
head and neck squamous cell carcinoma
pik3ca mutation
Online Access:https://journals.lww.com/10.4103/ejcrp.eJCRP-D-22-00018
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items